FKBPL Regulates Estrogen Receptor Signaling and Determines Response to Endocrine Therapy

Cancer Research - United States
doi 10.1158/0008-5472.can-09-2515
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Neoadjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer

JAMA Oncology
Cancer ResearchOncology
2016English

Phosphatidyl-Inositol-3-Kinase Alpha Catalytic Subunit Mutation and Response to Neoadjuvant Endocrine Therapy for Estrogen Receptor Positive Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2009English

Estrogen-Related Receptor Regulates Osteoblast Differentiation via WNT/ -Catenin Signaling

Journal of Molecular Endocrinology
EndocrinologyMolecular Biology
2012English

WNT4 Mediates Estrogen Receptor Signaling and Endocrine Resistance in Invasive Lobular Carcinoma Cell Lines

Breast Cancer Research
Cancer ResearchOncology
2016English

Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2015English

Estrogen Receptor Regulates E2F1 Expression to Mediate Tamoxifen Resistance

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2010English

Impact of Adding the Multikinase Inhibitor Sorafenib to Endocrine Therapy in Metastatic Estrogen Receptor-Positive Breast Cancer

Future Oncology
MedicineCancer ResearchOncology
2014English

Specific Binding of Estrogen Receptor to the Estrogen Response Element.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1989English

Nuclear Receptor CAR-ERα Signaling Regulates the Estrogen Sulfotransferase Gene in the Liver

Scientific Reports
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy